Post by STENTiT

Our work doesn’t stop on a lab bench: it continues with every patient treated and every data point collected. That’s what keeps us going. At LINC – Leipzig Interventional Course this year, prof. Marianne Brodmann shared updates from our ongoing clinical trial for patients at risk of critical limb-threatening ischemia. We find it hard to explain how much moments like this matter. The long hours, the tough decisions, and the persistence in the development and testing of our new implants, the resorbable fibrillated scaffolds (RFS). Eerything is worth when moving in the right direction: better treatments for our patients. We stay focused. The trial goes on. And so does the work. 📸 Kim van Noort Bente de Kort Golo von Basum Bart Sanders #stentit #LINC #startup #medtech